Cas:130922-41-7 1,2-difluoro-4-methylsulfanylbenzene manufacturer & supplier

Chemical Name:1,2-difluoro-4-methylsulfanylbenzene

CAS.NO:130922-41-7

Synonyms:1,2-difluoro-4-methylsulfanyl-benzene;3,4-Difluorophenyl methyl sulphide;Benzene,1,2-difluoro-4-(methylthio);1,2-difluoro-4-methylthiobenzene;3,4-Difluorothioanisole;PC6190;1,2-difluoro-4-methanesulfanylbenzene;(3,4-difluorophenyl)(methyl)sulfane

Molecular Formula:C₇H₆F₂S

Molecular Weight:160.18400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:181ºC at 760 mmHg

Density:1.23g/cm3

Index of Refraction:1.521

PSA:25.30000

Exact Mass:160.01600

LogP:2.68670

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2-difluoro-4-methylsulfanyl-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3,4-difluorophenyl)(methyl)sulfane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Difluorothioanisole Use and application,1,2-difluoro-4-methanesulfanylbenzene technical grade,usp/ep/jp grade.

Related News: Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 1,2-difluoro-4-methylsulfanylbenzene manufacturer Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 1,2-difluoro-4-methylsulfanylbenzene supplier The number of Americans living with Alzheimer’s is expected to more than double to around 13 million by 2050, according to the Alzheimer’s Association. 1,2-difluoro-4-methylsulfanylbenzene vendor The Covington inquiry is significant because Lilly’s handling of any employee allegations is likely to be considered by U.S. prosecutors as they weigh whether there are grounds to pursue criminal charges, seek civil action, or decline to bring a case at all, several legal experts said. 1,2-difluoro-4-methylsulfanylbenzene factory After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.